SEBI February 2026 ICDR master circular: the consolidated IPO and disclosure rulebook for primary markets
SEBI's 9 February 2026 ICDR master circular (doc 99611) consolidates every direction for public issues, rights issues and issuer disclosure - here is what it means for IPO pricing and listing gains today.
On 9 February 2026, the Securities and Exchange Board of India (SEBI) published its Master Circular for Issue of Capital and Disclosure Requirements (ICDR), filed as document 99611 on sebi.gov.in. The circular consolidates every operative direction for public issues, rights issues and issuer disclosure under the SEBI (ICDR) Regulations, 2018 into a single reference. For anyone reading the tape before the open, this is not a market-moving headline in the way an earnings miss is — it is the rulebook that decides how the next wave of IPOs gets priced, disclosed and listed, and it deserves a slot in any serious pre-open checklist.
This edition of Markets Pre-Open takes a primary-market lens. Rather than guess intraday index levels that will only be set when the bell rings, we anchor to what is verifiable on the official record: the 9 February 2026 ICDR consolidation, recent primary-market outcomes Oquilia has already reported, and the monetary backdrop set by the Reserve Bank of India.
Market Snapshot
The single most important structural item on the primary-market screen this morning is the ICDR master circular dated 9 February 2026. A SEBI master circular does not create new law; it gathers scattered circulars issued under the SEBI (ICDR) Regulations, 2018 into one document so that issuers, merchant bankers and investors work from a common text. The February 2026 edition (doc 99611) covers public issues, rights issues and the disclosure norms that sit around them.
For context, the primary market has been active into this consolidation. The table below sets out the verified reference points that frame today's equity primary market.
| Reference point | Figure | Source / date |
|---|---|---|
| ICDR master circular | Doc 99611 | SEBI, 9 February 2026 |
| Governing regulations | SEBI (ICDR) Regulations, 2018 | SEBI |
| Manipal Health IPO size | Rs 8,000 crore | Oquilia coverage, price band Rs 560-590 |
| Indo-MIM listing | Rs 700 vs Rs 485 issue price | Oquilia coverage |
| Monthly SIP inflows | Rs 31,781 crore (June 2026) | AMFI |
| RBI repo rate | 5.25% | RBI MPC, 8 April 2026 |
The repo rate stands at 5.25% following the RBI Monetary Policy Committee decision of 8 April 2026, the second consecutive pause after the February 2026 hold, per rbi.org.in. A stable policy rate matters for the primary market because it steadies the discount rate against which fresh issuers are valued; sharp rate moves are what typically compress IPO pricing windows.
What Moved Yesterday
The clearest signal from recent sessions has been the divergence between the IPO pipeline and the listing tape. On the pipeline side, Oquilia reported Manipal Health Enterprises opening a Rs 8,000 crore issue at a price band of Rs 560-590 per share — a large-cap primary raise that tests demand at the top end of the market-cap spectrum. Large offers of this size are precisely the issuers the ICDR disclosure norms are built to police, since the retail cheque count runs into lakhs.
On the listing side, Indo-MIM listed at Rs 700 against an issue price of Rs 485, a 44.3% listing-day premium on the reference price per Oquilia's earlier report. That gap between issue price and first trade is the headline number retail investors chase, and it is also the number SEBI's disclosure regime tries to keep honest: the offer document must lay out the basis of the issue price so that a Rs 485-to-Rs 700 move rests on disclosed fundamentals rather than sentiment alone.
Underneath the primary market, retail flows stayed firm. Systematic investment plan (SIP) contributions reached Rs 31,781 crore in June 2026 according to the Association of Mutual Funds in India (amfiindia.com). That monthly cheque is the demand cushion sitting under both the secondary and primary markets — a steady bid that absorbs new paper even on choppy days. The table below summarises the three moves worth carrying into today.
| Development | Number | Read-through |
|---|---|---|
| Manipal Health IPO | Rs 8,000 crore at Rs 560-590 | Large-cap primary supply |
| Indo-MIM listing | Rs 700 vs Rs 485 (+44.3%) | Listing-day demand intact |
| June 2026 SIP inflows | Rs 31,781 crore | Structural retail bid |
Read together, these three data points describe a primary market with live supply, healthy listing appetite and a Rs 31,781 crore monthly demand base — the conditions under which a consolidated ICDR rulebook actually gets exercised rather than sitting idle.
What to Watch Today
The practical watch-list for a primary-market participant this morning is built around the 9 February 2026 circular rather than a macro data release. Three things deserve attention.
First, the disclosure baseline. The ICDR master circular consolidates directions under the SEBI (ICDR) Regulations, 2018 covering public issues, rights issues and issuer disclosures. If you are evaluating any live offer, the red-herring prospectus should now map cleanly to the February 2026 consolidation — a mismatch is a flag, not a footnote.
Second, the monetary backdrop. The RBI repo rate is 5.25% as of the 8 April 2026 MPC decision, with the policy stance described as neutral. Any shift in that rate feeds directly into the cost of equity used to value fresh issuers, so watch RBI communications on rbi.org.in for the next scheduled review before assuming today's pricing math holds.
Third, the tax arithmetic on any listing gain. Short-term capital gains on listed equity are taxed at 20% and long-term gains above the Rs 1.25 lakh annual exemption at 12.5%, both effective from Budget 2024 (23 July 2024). A listing-day flip like Indo-MIM's Rs 485-to-Rs 700 move is a short-term gain taxed at 20%, a number every IPO applicant should net out before celebrating the premium.
For readers modelling how a primary-market allocation compounds, three Oquilia tools do the arithmetic: the SIP calculator for staggered monthly deployment, the lumpsum calculator for one-shot IPO allotments, and the step-up SIP calculator for contributions that rise with income. Against the Rs 31,781 crore of June 2026 SIP flow, these are the mechanics through which retail money actually reaches new issues.
The table below distils the watch-list into a single view.
| Watch item | Anchor figure | Where to verify |
|---|---|---|
| ICDR disclosure baseline | Doc 99611, 9 February 2026 | sebi.gov.in |
| Policy rate backdrop | Repo 5.25%, 8 April 2026 | rbi.org.in |
| Listing-gain tax | STCG 20%, LTCG 12.5% above Rs 1.25 lakh | Budget 2024 |
None of these is a same-day catalyst on its own. Together they are the framework that decides whether the next Manipal-sized issue prices cleanly and whether the next Indo-MIM-style listing pop rests on disclosed value or on froth.
FAQ
What is the SEBI ICDR master circular dated 9 February 2026?
It is a consolidated document (doc 99611 on sebi.gov.in) that gathers the operative directions applicable to public issues, rights issues and issuer disclosures under the SEBI (ICDR) Regulations, 2018 into one reference. A master circular does not introduce fresh law; the February 2026 edition simply puts the existing ICDR directions in one place so issuers and investors work from a single text.
Does the ICDR master circular change how IPOs are priced?
No. The 9 February 2026 circular consolidates disclosure and issue-process directions rather than setting prices. Pricing remains a function of the book-building process and the basis-of-issue-price disclosures in the offer document, both governed by the SEBI (ICDR) Regulations, 2018 that the circular consolidates.
How are gains from an IPO listing taxed in FY 2025-26?
Gains on listed equity held for up to a year are short-term and taxed at 20%; gains on holdings beyond a year are long-term and taxed at 12.5% on the amount above the Rs 1.25 lakh annual exemption, both effective from Budget 2024 (23 July 2024). A listing-day sale — such as Indo-MIM's move from a Rs 485 issue price to a Rs 700 first trade — is a short-term gain taxed at 20%.
What does the June 2026 SIP figure tell primary-market investors?
The Association of Mutual Funds in India reported Rs 31,781 crore of SIP inflows in June 2026. That recurring monthly contribution is a structural demand base that helps absorb new equity supply, including large IPOs such as the Rs 8,000 crore Manipal Health issue, without relying purely on foreign or institutional appetite.
Where does the RBI repo rate sit and why does it matter for IPOs?
The repo rate is 5.25% following the RBI MPC decision of 8 April 2026, a neutral-stance pause. The policy rate feeds into the cost of equity used to value new issuers, so a stable 5.25% supports steadier IPO pricing windows than a volatile rate environment would.
How can I estimate what an IPO allocation might grow into?
Use Oquilia's lumpsum calculator for a one-shot allotment, the SIP calculator if you deploy in monthly tranches, and the step-up SIP calculator for contributions that rise each year. These model compounding on your chosen return assumption; they do not predict any specific IPO outcome.
Where can I read the ICDR master circular in full?
The full text is published on the SEBI legal portal at sebi.gov.in under legal/master-circulars/feb-2026 as document 99611, dated 9 February 2026. Always read the primary source before acting on any summary, and check the SEBI glossary entry for how the regulator's directions fit together.